Wetter Pharma-Fertigung GmbH & Co. KG (final filling of vials (primary packaging), performing sterility testing)

The drug is intended for long-term enzyme replacement therapy in patients with mucopolysaccharidosis type I (MPS I). It is used to treat manifestations of the disease that are not related to nervous system involvement.

Dosage form: concentrate for infusion solution

ATC: A16AB05